These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7037180)

  • 21. [Low-dose CDDP and 5-FU for head and neck cancer patients].
    Fujii M; Kanke M; Tomita T
    Gan To Kagaku Ryoho; 1999 Oct; 26(11):1542-7. PubMed ID: 10553410
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A cooperative phase II study of cisplatin in patients with head and neck cancer].
    Inuyama Y; Takeda C
    Gan To Kagaku Ryoho; 1986 Feb; 13(2):232-8. PubMed ID: 3004363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of paclitaxel, ifosfamide, and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
    Shin DM; Glisson BS; Khuri FR; Hong WK; Lippman SM
    Semin Oncol; 1998 Apr; 25(2 Suppl 4):40-4; discussion 45-8. PubMed ID: 9578061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paclitaxel, carboplatin, and long-term continuous 5-fluorouracil infusion in the treatment of upper aerodigestive malignancies: preliminary results of phase II trial.
    Hainsworth JD; Meluch AA; Greco FA
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-38-S19-42. PubMed ID: 9427264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of advanced squamous cell carcinoma of the head and neck with cisplatin, bleomycin, and methotrexate (PBM).
    Ervin TJ; Weichselbaum R; Miller D; Meshad M; Posner M; Fabian R
    Cancer Treat Rep; 1981; 65(9-10):787-91. PubMed ID: 6168371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemo-immunotherapy in advanced head and neck cancer.
    Recchia F; Sica G; De Filippis S; Rosselli M; Pompili P; Saggio G; Rea S
    Anticancer Res; 1999; 19(1B):773-7. PubMed ID: 10216492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined-modality therapy for esophageal cancer: phase I trial of escalating doses of paclitaxel in combination with cisplatin, 5-fluorouracil, and high-dose radiation before esophagectomy.
    Weiner LM; Colarusso P; Goldberg M; Dresler C; Coia LR
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-93-S19-95. PubMed ID: 9427276
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neoadjuvant chemotherapy in squamous cell carcinoma of the esophagus using low dose continuous infusion 5-fluorouracil and cisplatin: results of a prospective study.
    Aroori S; Parshad R; Kapoor A; Gupta SD; Kumar A; Chattophadyay TK
    Indian J Cancer; 2004; 41(1):3-7. PubMed ID: 15105572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Salvage chemotherapy with PEM and long-CF regimen in CDDP refractory advanced head and neck cancer.
    Kohno N; Ichikawa G; Shirasaka T; Inuyama Y; Kawaida M; Ohnuma T
    Gan To Kagaku Ryoho; 1995 Aug; 22 Suppl 3():209-14. PubMed ID: 7661582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination of mitomycin, vindesine, and cisplatin in the treatment of head and neck squamous cell carcinoma.
    Leyvraz S; Barrelet L; Savary M; Bernasconi S
    Cancer Treat Rep; 1987 Jan; 71(1):81-2. PubMed ID: 3791271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paclitaxel, cisplatin and 5-fluorouracil in recurrent squamous cell carcinoma of the head and neck: a phase II trial from an Italian cooperative group.
    Benasso M; Ponzanelli A; Merlano M; Numico G; Ricci I; Vigo V; Grossi F; Amadori D; Cavallo G; Capaccetti B; Taveggia P; Boni L; Rosso R
    Acta Oncol; 2006; 45(2):168-74. PubMed ID: 16546862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integration of safe initial combination chemotherapy (without cisplatin) with a high response rate and local therapy for untreated stage III and IV epidermoid cancer of the head and neck: 5-year survival data.
    Price LA; MacRae K; Hill BT
    Cancer Treat Rep; 1983 Jun; 67(6):535-9. PubMed ID: 6190557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intensive chemoradiotherapy as a primary treatment for organ preservation in patients with advanced cancer of the head and neck: efficacy, toxic effects, and limitations.
    Hanna E; Alexiou M; Morgan J; Badley J; Maddox AM; Penagaricano J; Fan CY; Breau R; Suen J
    Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):861-7. PubMed ID: 15262764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A phase I/II study of paclitaxel plus cisplatin as first-line therapy for head and neck cancers: preliminary results.
    Hitt R; Hornedo J; Colomer R; Mendiola C; Brandariz A; Sevilla E; Alvarez-Vicent J; Cortés-Funes H
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):50-4. PubMed ID: 8643971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cis-dichlorodiammineplatinum(II), methotrexate, bleomycin, and vincristine in head and neck cancer: a pilot study.
    King GW; Halpin JJ; Smith RE; Batley F; Schuller DE
    Cancer Treat Rep; 1979; 63(11-12):1735-8. PubMed ID: 93508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Primary chemotherapy of advanced squamous epithelial carcinomas of the head and neck].
    Bruntsch U; Hiller T; Wandt H; Wolff L; Theissing J; Gallmeier WM
    Dtsch Med Wochenschr; 1985 Dec; 110(49):1889-92. PubMed ID: 2415315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized trial of cisplatin (CACP) + 5-fluorouracil (5-FU) infusion and CACP + 5-FU bolus for recurrent and advanced squamous cell carcinoma of the head and neck.
    Kish JA; Ensley JF; Jacobs J; Weaver A; Cummings G; Al-Sarraf M
    Cancer; 1985 Dec; 56(12):2740-4. PubMed ID: 3902199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination chemotherapy with cisplatin, bleomycin, and methotrexate in patients with advanced head and neck cancer.
    Von Hoff DD; Alberts DS; Mattox DE; Coulthard S; Dana B; Manning M; Myers JW; Griffin CB
    Cancer Clin Trials; 1981; 4(2):215-8. PubMed ID: 6166408
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of methotrexate and 5-FU for recurrent head and neck cancer.
    Jacobs C
    Cancer Treat Rep; 1982 Nov; 66(11):1925-8. PubMed ID: 6754074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Experiences using combination chemotherapy with cis-platinum, bleomycin and methotrexate in the management of advanced squamous cell carcinomas of the head and neck (author's transl)].
    Jahnke V
    HNO; 1980 Dec; 28(12):405-8. PubMed ID: 6161913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.